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Abstract
Background: Plant lectins such as Galanthus nivalis agglutinin (GNA) and Hippeastrum hybrid agglutinin
(HHA) are natural proteins able to link mannose residues, and therefore inhibit HIV-target cell
interactions. Plant lectins are candidate for microbicide development.
Objective: To evaluate the activity against HIV of the mannose-specific plant lectins HHA and GNA at
the cellular membrane level of epithelial cells and monocyte-derived dendritic cells (MDDC), two potential
target cells of HIV at the genital mucosal level.
Methods: The inhibitory effects of HHA and GNA were evaluated on HIV adsorption to genital epithelial
HEC-1A cell line, on HIV transcytosis throughout a monolayer of polarized epithelial HEC-1A cells, on
HIV adsorption to MDDC and on transfer of HIV from MDDC to autologous T lymphocytes.
Results: HHA faintly inhibited attachment to HEC-1A cells of the R5-tropic HIV-1Ba-L strain, in a dose-
dependent manner, whereas GNA moderately inhibited HIV adsorption in the same context, but only at
high drug doses. Only HHA, but not GNA, inhibited HIV-1JR-CSF transcytosis in a dose-dependent manner.
By confocal microscopy, HHA, but not GNA, was adsorbed at the epithelial cell surface, suggesting that
HHA interacts specifically with receptors mediating HIV-1 transcytosis. Both plant lectins partially
inhibited HIV attachment to MDDC. HHA inhibited more efficiently the transfer of HIV from MDDC to
T cell, than GNA. Both HHA and GNA lacked toxicity below 200 µg/ml irrespective the cellular system
used and do not disturb the monolayer integrity of epithelial cells.
Conclusion: These observations demonstrate higher inhibitory activities of the lectin plant HHA by
comparison to GNA, on HIV adsorption to HEC-1A cell line, HIV transcytosis through HEC-1A cell line
monolayer, HIV adsorption to MDDC and HIV transfer from MDDC to T cells, highlighting the potential
interest of HHA as effective microbicide against HIV.
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Background
Heterosexual contact is the primary mode of human
immunodeficiency virus type 1 (HIV-1) transmission
worldwide. The majority of new HIV-1-infected people
are women. Effective topical microbicides, as molecules
with potent activity against HIV-1, inserted into the vagina
prior to sexual intercourse, would offer an alternative to
condom use that would be controlled by the receptive
partner [1].
Plant lectins represent a well-defined class of antiretroviral
compounds that are most advantageous than other antivi-
ral drugs: lectins are natural and not synthetic products
(proteins) and target the sugar moieties of a wide variety
of glycoproteins [2,3]. Galanthus nivalis agglutinin (Snow-
drop) (GNA) has specificity for terminal α(1–3)-linked
mannose residues, whereas Hippeastrum hybrid agglutinin
(Amaryllis) (HHA) recognizes both terminal and internal
α(1–3)- and α(1–6)-linked mannose residues [4]. These
lectins occur as tetramers exhibiting a molecular mass of
50 kDa. They are potent and highly selective inhibitors of
the spread of HIV by virus- to- lymphocytes, as well as
infected lymphocytes- to- uninfected lymphocytes. HHA
and GNA selectively inhibited a wide variety of HIV-1 and
HIV-2 strains and clinical (CXCR4- and CCR5-using) iso-
lates in different cell types [4]. It was also shown that these
lectins inhibited infection of T lymphocytes by a variety of
mutant virus strains, but also prevented syncytium forma-
tion between persistently HIV-infected cells and unin-
fected T lymphocytes [4]. There is strong evidence that
plant lectins with anti-HIV activity predominantly target
the heavily glycosylated gp120 envelope glycoprotein, as
assessed by HIV-lectins pre-incubation assays [4]. In con-
trast, no marked lectin-lymphocyte interactions were
observed [4]. In addition, HHA and GNA efficiently abro-
gated the DC-SIGN-directed HIV-1 capture in DC-SIGN-
expressing B-lymphoblast Raji cells (Raji/DC-SIGN) and
its subsequent transfer to CD4+ T lymphocytes [5]. HHA
and GNA are also perfectly fitted to microbicide guide-
lines in the way they are odorless, tasteless, colorless, not
mitogenic and not anti-metabolically active at anti-viral
concentrations [4].
Since early microbicide trials raised concerns about testing
incompletely characterized compounds in humans [6],
we propose to complete the in vitro pre-clinical evaluation
of microbicide molecule candidates against HIV-1 adsorp-
tion on epithelial cells, and against HIV-1 transcytosis
through a tight monolayer of epithelial cells used as an in
vitro model mimicking the penetration of HIV-1 through
unstratified epithelia [7]. Indeed, epithelial cells represent
the most important interface between host and environ-
ment. Hocini et al. have previously hypothesized that sim-
ple epithelial monolayers, such as the endocervix and
rectal mucosae, may support rapid transcellular transport
(or " transcytosis ") from the apical to basolateral side of
the cell, and thus provide viral access to the target cells of
the submucosa, such as dendritic cells, CD4+ T cells and
macrophages [8].
In the present study, we thus aimed at characterizing
whether interactions exist between mannose-specific
lectins and mannosylated HIV-interacting molecules.
Indeed, HIV was described to interact with a large number
of molecules onto cell surface during the adsorption
phase. If some of these receptors are mannosylated close
to the HIV-binding sites, the plant lectins may recognise
such mannosylated residues, and may mask the HIV bind-
ing site by steric hindrance, thus limiting HIV attachment
onto cells. The effects of carbohydrate-binding plant
lectins on T lymphocytes [4] and on DC-SIGN+ B-lym-
phoblast Raji cells [5] have been previously investigated.
To complete these latter studies, we herein evaluated the
inhibitory effect of HHA and GNA on the attachment of
HIV on other possible mucosal target cells, including epi-
thelial and dendritic cells.
Methods
Cells lines, virus strains and plant lectins
the epithelial cell line HEC-1A was maintained in RPMI
1640 containing 10% FCS and antibiotics (100 µg of
streptomycin per ml, 100 IU of penicillin per ml). Primary
HIV-1NDK  X4-tropic viruses (gift from Prof. F. Barré-
Sinoussi, Institut Pasteur, Paris, France) were grown in
peripheral blood lymphocytes (PBL) of healthy donors
stimulated with phytohemagglutinin-P (PHA; Sigma-
Aldrich, Saint Louis, MO) and interleukin-2 (IL-2; Pepro-
tech Inc, Rocky Hill, NJ). R5-tropic HIV-1J-RCSF and HIV-
1Ba-L were amplified in monocyte-derived macrophages
(MDM) of healthy donors. Tropism of viruses was deter-
mined using U87 cells (provided by Dr. E. Menue, Institut
Pasteur) transfected with DNA encoding for human CD4,
CCR5, or CXCR4. HIV was quantified in cell culture super-
natants by means of the DuPont HIV-p24 antigen ELISA
(HIV-1 core profile ELISA; DuPont de Nemours, Les Ulis,
France). The mannose-specific lectins HHA and GNA were
derived and purified from the bulbs of these plants, as pre-
viously described [9]. Mannan was provided by Sigma.
In vitro differentiation of monocyte-derived dendritic cells 
(MDDC)
MDDC were generated from monocytes as previously
described. Briefly, peripheral blood mononuclear cells
(PBMC) were isolated from buffy coats of healthy adult
donors by Ficoll density gradient centrifugation on MSL
(Medium for Separate of Lymphocytes, Eurobio, Les Ulis,
France). The percentage of monocytes was determined by
flow cytometry on a FACScalibur (Becton Dickinson,
Montain View, CA) using forward scatter and side scatter
properties (FSC/SSC). PBMC were re-suspended in RPMIJournal of Translational Medicine 2007, 5:28 http://www.translational-medicine.com/content/5/1/28
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1640medium supplemented with L-glutamine (BioWhit-
taker Europe, Verviers, Belgium), penicillin (100 IU/ml)
and streptomycin (100 µg/ml) (Gibco BRL, Paisley, Scot-
land). Cells were seeded into 24 well-plates (Costar, Cam-
bridge, MA) at the concentration 1 × 106 adherent cells/
ml. Cells were incubated at 37°C for 45 min. Non-adher-
ent cells were removed by 4 gently washes. Adherent
monocytes were further incubated in RPMI medium sup-
plemented with 10% fetal calf serum (FCS), L-glutamine,
and antibiotics in the presence of 10 ng/ml rhIL-4 and 10
ng/ml rhGM-CSF (both from R&D Systems, Oxon, UK),
in order to differentiate MDDC. Half of the medium,
including all supplements, was replaced every 2 days.
After 6 days of culture, non-adherent cells corresponding
to the DC-enriched fraction were harvested, washed, and
used for subsequent experiments. Flow cytometry analysis
demonstrated that the DC were 90% or more pure DC at
an immature stage (CD14-, CD16-, CD1a+, CD83-, DC-
SIGN+).
Isolation of autologous T lymphocytes
PBL were subsequently prepared from the monocyte-
depleted cell fraction. PBL were cultured for 48 h in fresh
medium supplemented with PHA (2.5 µg/ml) and IL-2 (1
µg/ml). PBL were then washed and further cultured in
growth medium containing IL-2 (1 µg/ml) for 24 h.
Cytotoxicity assay
the cytotoxicity of the plant lectins against epithelial cells
and MDDC was analysed using the MTT (3- [4,5-dimeth-
ylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay
(Sigma). Briefly, cells were seeded onto 96-well plates at a
density of 2 × 105 cells/well and incubated for 24 h at
37°C prior to drug exposure. On the day of treatment, cul-
ture medium was carefully aspirated from the wells and
replaced with fresh medium containing the plant lectins
at concentrations ranging from 1 to 500 µg/ml. Triplicate
wells were used for each treatment. The cells were incu-
bated with the various compounds for 24 h at 37°C in a
humidified 5% CO2 atmosphere. To each well, 20 µl of
MTT (0.5 mg/ml final concentration) was added and the
plates were incubated at 37°C for 4 h to allow MTT to
form formazan crystals by reacting with metabolically
active cells. The formazan crystals were solubilized 30 min
at 37°C in a solution containing 10% sodium dodecyl
sulphate in 0.01 M HCl. The absorbance of each well was
measured in a microtitre reader at 490 nm. To translate
the OD490 values into the number of live cells in each well,
the OD490 values were compared with those of standard
OD490 versus cell number curves generated for each cell
type. The percentage survival was calculated using the for-
mula :
% survival = live cell number (test)/live cell number (con-
trol) × 100
Epithelial monolayer integrity
the effect of the plant lectins on their ability to maintain
an intact epithelium was determined by measuring tran-
sepithelial resistance (TER). HEC-1A cells were grown as a
tight polarized monolayer on a permeable support of 0.4
µm-pore-diameter polycarbonate (Transwell, Costar,
Cambridge, Mass.). Apical and basolateral media were
replaced, and TER was measured daily with a Millicell-ERS
(electrical resistance system) instrument (Millipore Cor-
poration, Bedford, Mass.). When plateau TER was
reached, plant lectins or media alone were added in dupli-
cate wells, and the TER was measured at 30 min and 2, 4,
9, and 24 h. The epithelial resistance was expressed as fol-
lows :
epithelial resistance = (Ω/cm2) - the resistance of tran-
swells without cells.
HIV cell-free particles transcytosis
the epithelial cell line HEC-1A was grown as a tight polar-
ized monolayer on a permeable support of 0.4-µm-pore-
diameter polycarbonate (Transwell), as previously
described [10]. The tightness of the monolayer of HEC-1A
cells was monitored by measuring resistivity above 200 Ω/
cm2. HIV-1 (5 ng of p24 antigen) was added together with
increasing doses of each plant lectin or mannan (100 µg/
ml) on the apical side of the HEC-1A monolayer. Cells
were incubated for 1 h at 37°C. HIV-1 transcytosis was
assessed by detecting the presence of p24 antigen (HIV-1
core profile ELISA) in the basolateral chamber of the tran-
swell. The inhibition of transcytosis was expressed as the
percentage of p24 antigen recovered in the basolateral
chamber in the presence of each plant lectin by compari-
son to that recovered without the plant lectins.
HIV-1 attachment assay on epithelial cells
HEC-1A cells, seeded at confluency in 48-well plates, were
incubated with increasing doses of each lectins or mannan
(100 µg/ml) and HIV-1 (5 ng p24 antigen). Each sample
was performed in duplicate. After 1 h of incubation, unat-
tached virus was removed (4 washes) and cells were lysed
(1% Triton X-100 for 45 min at 37°C). Cell lysates were
harvested and centrifuged at 1,800 rpm for 5 min. The
amount of HIV-p24 antigen associated to cell lysates was
determined using the HIV-1 p24 core profile ELISA.
HIV-1 attachment on MDDC
to assess the attachment of HIV-1 to MDDC, the cells were
washed 2 times after 6 days of differentiation and seeded
into 96-well culture plates (1 × 105 cells/well). HIV-1 (1
ng p24 antigen) and increasing doses of each plant lectin
or mannan (100 µg/ml) were added on cells and incu-
bated for 1 h at 37°C in a 5% CO2 atmosphere. Each sam-
ple was performed in triplicate. After 4 washes to remove
the unattached virus, cells were lysed by incubation for 45Journal of Translational Medicine 2007, 5:28 http://www.translational-medicine.com/content/5/1/28
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min at 37°C with 1% Triton X-100. Cell lysates were har-
vested and centrifuged at 1,800 rpm for 5 min. The
amount of cell-associated HIV-1 was evaluated using p24
antigen capture ELISA.
MDDC-mediated infection of autologous T cells
to assess the transmission of HIV-1 from MDDC to autol-
ogous T-cells, MDDC were incubated into 96-well culture
plates (1 × 105 cells/well) and infected with HIV-1 (0.5 ng
p24 antigen) in the presence of increasing concentrations
of each plant lectin or mannan (100 µg/ml) for 3 h at
37°C in a 5% CO2 atmosphere. Cells were washed four
times and autologous stimulated T cells were added onto
HIV-exposed MDDC at a DC:T-cell ratio of 1:5. Each sam-
ple was performed in triplicate. Culture supernatants were
harvested every 3 days and fresh medium was added.
Supernatants were inactivated with 1% Triton X-100 and
frozen at -20°C. The viral production by T lymphocytes
was evaluated at the sixth day of the co-culture by meas-
urement of p24 antigen in supernatants using capture
ELISA.
Confocal microscopy
confluent epithelial cells HEC-1A were trypsinized,
washed, and 2 × 105 cells were adsorbed on a microscopy-
adapted slide for 3 days. After 6 days of differentiation
MDDC are washed and 2 × 105 cells were adsorbed on a
microscopy-adapted slide. Cells were incubated with or
without HHA-TRITC or GNA-TRITC (200 µg/ml; Eylabs)
at 4°C for 30 min. Cells were washed with PBS 0.01%
azide 0.5% BSA and then fixed with 1% paraformalde-
hyde. The coverslides were mounted in Mowiol (Sigma-
Aldrich). Fluorescence analysis was performed with a
Zeiss LSM510 confocal microscope.
Statistical analysis
unpaired and non-parametric Mann-Whitney U-test was
performed for all tests to determine the statistical signifi-
cance of the data. P < 0.05 was considered the level of sta-
tistical significance.
Results
HHA and GNA activities in the epithelial cell line HEC-1A
(i) Toxicity
Any topical microbicide approved for human use first
need to be evaluated for epithelial toxicity, because of the
direct contact between the product and the vaginal
mucosal surface. Thus, non-toxic concentrations of the
plant lectins were determined by culturing the epithelial
cell line, HEC-1A, for 24 h in the presence of different lec-
tin concentrations (1 µg/ml to 200 µg/ml) or medium
(Fig. 1A). Plant lectins concentrations that gave culture
viabilities of more than 80% compared to control cultures
were considered to be non-toxic and were further evalu-
ated. Overall, the products exhibited no measurable toxic-
ity towards HEC-1A epithelial cells within a tested
concentration range of 1 to 200 µg/ml.
(ii) Epithelial monolayer integrity
The ability of mucosal epithelial cells to maintain an
intact polarized monolayer in the presence of the plant
lectins is a possible predictor of the safety of products on
vaginal tissues. Thus, HHA and GNA were added to con-
fluent HEC-1A cell-monolayers, as determined by TER =
200 Ω/cm2. The TER was evaluated at 24 h after addition
(A). Non-toxic concentration of the study plant lectins in epi- thelial cell line (HEC-1A) and primary immune cells (MDDC  and MDM) Figure 1
(A). Non-toxic concentration of the study plant lectins in epi-
thelial cell line (HEC-1A) and primary immune cells (MDDC 
and MDM). HEC-1A and primary immune cells were cultured 
with concentrations of products for 24 h. After washing, cul-
ture viability was determined by using the MTT-cytotoxicity 
assay. The values given are the percentage of viability. (B) and 
(C). Effect of HHA and GNA on HEC-1A epithelial monol-
ayer integrity. HEC-1A cells were grown on transwell sup-
ports and allowed to form intact monolayer (5 to 7 days). 
Non-toxic concentrations of each lectins were added to the 
apical side of the transwell, and epithelial integrity was meas-
ured at 30 min and 2, 4, 9, and 24 h by using the Minicell-ERS 
instrument. The data shown are the averages from duplicate 
wells ± 1 standard error of the mean after product addition.
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of the plant lectins. HHA up to 200 µg/ml (Fig. 1B) and
GNA up to 200 µg/ml (Fig. 1C) did not measurably affect
the integrity of the epithelial barrier. Of note, the TER of
the control cultures, without the plant lectins, did not vary
more than 25% over the 24 h period.
(iii) Effect of plant lectins on HIV-1 attachment on HEC-1A
Considering that both HHA and GNA were non-toxic in
the epithelial cell system, we further investigated the inhi-
bition of HIV adsorption on the apical side of HEC-1A by
the compounds. Cells were thus incubated with HIV-1Ba-L
in the presence or absence of different concentrations of
HHA or GNA. As depicted in Figure 2A, HHA faintly
decreased the attachment of HIV-1Ba-L on epithelial cells
(range: 12–17%). Interestingly, GNA afforded a 33%
decrease of HIV adsorption only at a concentration of 100
µg/ml. In order to evaluate whether the observed effects of
the plant lectins are linked to molecules implicated in HIV
attachment towards genital epithelial cells, such as gly-
cosaminoglycans (GAG) heparan sulfates, we assessed the
role of plant lectins on the attachment of X4-tropic
viruses, known to interact very efficiently with heparan
sulfate [11] and data not shown]. Thus, cells were incu-
bated with HIV-1NDK (Fig. 2B) in the presence or absence
of different concentrations of HHA and GNA. As depicted
in Figure 2B, none of the plant lectins, whatever the con-
centration, inhibited HIV-1NDK attachment on HEC-1A
cells. These data suggested that HHA and GNA did not
interact with HIV recognition sites on GAG. In addition,
mannan (100 µg/ml) did not decrease HIV adsorption on
HEC-1A cells whatever the viral strain used (Fig. 2A and
Fig. 2B). To investigate the efficiency of each lectin to
interact with epithelial cell's receptors, labeled HHA and
GNA were incubated with epithelial cells. As depicted in
Figure 2C, only HHA but not GNA interacted with recep-
tors expressed at the surface of HEC-1. Moreover, the pre-
incubation of GNA with epithelial cells followed with
several washes did not inhibit viral attachment whereas
the preincubation of GNA with R5 viral particles induced
an inhibition of 35 ± 5% of R5 HIV-1 attachment on epi-
thelial cells (data not shown), similarly to the experimen-
tation made without preincubation. Altogether these
results suggest that GNA interrupts the virus attachment
process by interfering with the virus envelope glycopro-
tein.
(iv) Efficacy of plant lectins on HIV-1 transcytosis through a tight 
epithelial cells monolayer
To evaluate the capacity of each plant lectin to inhibit in
vitro HIV-1 transcytosis through genital epithelial cells,
such as HEC-1A cells, we used a dual-chamber model in
which the apical chamber consisted of a confluent mon-
olayer of HEC-1A cells, and the basal chamber contained
fresh medium. Cell-free virus (HIV-1J-RCSF) was deposited
on the apical surface of HEC-1A cells with increasing con-
centrations of the plant lectins. The HIV-1J-RCSF strain was
used in this experiment due to the low transcytosis ability
of HIV-1Ba-L strain [8]. As shown in Figure 3A, HHA inhib-
ited transcytosis of cell-free HIV-1 in a dose-dependent
manner. Similarly to mannan (100 µg/ml) that inhibited
HIV transcytosis up to 41%, increasing concentrations of
HHA (range 1-10-100 µg/ml) afforded a 17%, 42% and
54% decrease of HIV-1JRCSF transcytosis, respectively (Fig.
3A). In contrast, GNA did not inhibit the transcytosis of
HIV-1 cell-free particles (Fig. 3B). Altogether, these results
suggest that HHA inhibited transcytosis by interacting
specifically with HEC-1A receptors involved in the HIV
transcytosis process [12].
Ability of lectins to inhibit attachment of HIV-1 cell-free par- ticles on epithelial cells Figure 2
Ability of lectins to inhibit attachment of HIV-1 cell-free par-
ticles on epithelial cells. HEC-1A cells were co-incubated 
with non-toxic concentrations of each lectins or mannan 
(100 µg/ml) and 5 ng of HIV-1Ba-L (A) or HIV-1NDK (B) virus 
were added for 1 h. Incubation with mannan was used as 
control. The quantity of attached virus was evaluated by 
measurement of p24 antigen by ELISA. Means of three inde-
pendent experiments are presented ; error bars represent 
standard deviations. (C) HEC-1A cells were incubated with 
or without each labelled-lectin at 4°C. Cells were then ana-
lyzed by confocal microscopy. * < 0.05.
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HHA and GNA activities in monocyte-derived dendritic 
cells
(i) Toxicity
Cellular viability was determined for MDDC by culturing
for 24 h in the presence of serial dilutions of the plant
lectins. Plant lectin concentrations that gave culture via-
bilities of more than 80% compared to control cultures
were considered to be non-toxic (Fig. 4A).
(ii) Efficacy of lectins against attachment of HIV-1 on MDDC
Intraepithelial and submucosal dendritic cells (DCs) and
CD4+ T lymphocytes are the predominant cell popula-
tions firstly targeted by HIV-1 [13]. Indeed, successful
transfer of virus across epithelial barriers would result in
HIV-1 capture by DC and subsequent transmission to
nearby CD4+ T cells or dissemination to draining lymph
nodes. We first investigated whether the plant lectins are
able to interact with receptors expressed at the surface of
monocyte-derived dendritic cells (MDDC). As depicted in
Figure 4B, both HHA and GNA interacted with receptors
expressed at the surface of MDDC, suggesting that these
(A). Lack of toxicity of HHA and GNA towards dendritic  cells (MDDC) Figure 4
(A). Lack of toxicity of HHA and GNA towards dendritic 
cells (MDDC). MDDC were cultured with concentrations of 
products for 24 h. After washing, culture viability was deter-
mined by using the MTT cytotoxicity assay. The values given 
are the percentage of viability. (B). Interactions of plant 
lectins with surface receptors of dendritic cells. Dendritic 
cells (MDDC) were incubated with or without each labelled-
lectin at 4°C. Cells were then analyzed by confocal micros-
copy. (C and D). Ability of lectins to inhibit uptake of HIV-
1Ba-L cell-free particles on dendritic cells. MDDC were co-
incubated with non-toxic concentrations of HHA (C), or 
GNA (D) or mannan (100 µg/ml) and 1 ng p24 antigen of 
HIV-1Ba-L were added for 1 h. The quantity of attached-virus 
was evaluated by measurement of p24 antigen by ELISA. 
Means of three independent experiments are presented ; 
error bars represent standard deviations. *< 0.05
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Ability of lectins to inhibit transcytosis of HIV-1J-RCSF free par- ticles through a tight monolayer of endometrial epithelial cell  (HEC-1A) Figure 3
Ability of lectins to inhibit transcytosis of HIV-1J-RCSF free par-
ticles through a tight monolayer of endometrial epithelial cell 
(HEC-1A). HIV-1J-RCSF (5 ng p24 antigen) was co-incubated 
with a non-toxic concentrations of each lectins or mannan 
(100 µg/ml) on the HEC-1A apical pole cultured in dual-
chamber by the transwell system for 1 h. Results of an exper-
iment performed in duplicate are expressed as the quantity 
of virus recovered in the basal chamber in the presence of 
HHA (A) and GNA (B), or in the absence of lectins. Means of 
three independent experiments are presented ; error bars 
represent standard deviations. *< 0.05, **< 0.01.
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plant lectins would interrupt the virus attachment process
by interfering both with the virus envelope glycoprotein
and with the receptors expressed at the surface of MDDC.
Then, we evaluated the effect of plant lectins on HIV-1
uptake by MDDC. Therefore, MDDC were incubated with
HIV-1Ba-L in the presence of increasing doses of each plant
lectin (Fig. 4C and Fig. 4D). Similarly to mannan (100 µg/
ml) that induced a 46% decrease of HIV adsorption on
MDDC, both HHA and GNA (100 µg/ml) inhibited the
virus attachment on MDDC, of 47.2 ± 5.5% and 43.1 ±
5.8%, respectively. No inhibition of HIV adsorption on
MDDC was observed for both lectins at lower concentra-
tions (1 and 10 µg/ml).
(iii) Efficacy of the plant lectins on HIV-1 transmission to T cell blasts 
by MDDC
We finally evaluated whether inhibition of attachment on
MDDC resulted in subsequent inhibition of HIV-1 trans-
mission to autologous T lymphocytes. MDDC were incu-
bated with HIV-1Ba-L in the presence of increasing doses of
each plant lectin. Free viral particles and plant lectins were
removed and autologous PBL were added. The pretreat-
ment of MDDC by each plant lectin resulted in a partially
reduced infection of autologous PBL by HIV-1 (Fig. 5). We
observed 26.9 ± 0.5% of inhibition of HIV transfer at a
concentration of 100 µg/ml of HHA and 15.3 ± 1.3% of
inhibition at a concentration of 100 µg/ml of GNA. In
these same experiments, we used blocking anti-DC-SIGN
mAb (clone 507) as positive control of inhibition of trans-
fer [14]. The addition of anti-DC-SIGN mAb inhibited
more than 43.8 ± 5.7% both R5- and X4- HIV-1 transfer
from MDDC to T cells (Fig. 5).
Discussion
The plan lectins HHA and GNA constitute two promising
microbicide molecules of great interest, capable to effi-
ciently inhibit the infection of T lymphocytes and PBMC
by a broad range of HIV strains [4]. This effect is mostly
due to direct interactions between the plant lectins and
mannose residues at the gp120 of the HIV-1 envelope and
thus inhibiting fusion rather adsorption of HIV [9]. How-
ever, anti-HIV effects resulting of interactions between
plant lectins and cellular HIV receptors were not pro-
foundly investigated. In addition, no direct interaction
between the plant lectins and CD4, CCR5, CXCR4 and
DC-SIGN was observed [4]. In the present study, we thus
aimed at characterizing whether interactions exist
between mannose-specific plant lectins and manno-
sylated HIV-interacting molecules expressed at the cell
surface. Indeed, HIV was described to interact with a large
number of molecules onto the cell surface during the
adsorption phase [2,15-19]. If some of these receptors are
mannosylated close to the HIV-binding sites, the plant
lectins may recognize such mannosylated residues, and
may mask the HIV binding site by steric hindrance, thus
limiting HIV attachment onto target cells. Therefore, we
particularly focused on the initial phase of virus adsorp-
tion.
We evaluated the effect of the plant lectins on HIV adsorp-
tion on genital epithelial cells. We found that HHA faintly
inhibited attachment of the R5-tropic HIV-1Ba-L strain, in
a dose-dependent manner, whereas GNA moderately
inhibited HIV adsorption in the same context, and only at
high drug doses. HSPG are known to be highly expressed
on HEC-1 cells [12], and are required for HIV-1 attach-
ment to epithelial cells [20]. HSPG interact with positively
charged-V3 loop of X4-tropîc HIV-1 gp120, and weakly
with less positively charged R5-tropic strains on epithelial
cells [12]. In our hands, GNA did not inhibit the attach-
ment of X4-tropic HIV-1 on epithelial cells, and did not
interact with epithelial cell surface. Thus, the preincuba-
tion of GNA with epithelial cells did not inhibit viral
attachment whereas the preincubation of GNA with R5-
tropic HIV-1 particles induced the inhibition of HIV-1
attachment on epithelial cells, suggesting that the antiviral
activity of GNA is likely related to its interaction with virus
particles. Indeed, altogether our results suggest that HIV-
1Ba-L interact with (a) membrane molecule(s) expressed
on apical side of epithelial cells during the attachment
phase which is (or are) (i) not an HIV-interacting GAG, as
indicated by our observations in the presence of X4-tropic
viruses, (ii) not C-type lectin(s), considering the absence
Ability of plant lectins to inhibit transfer of HIV-1Ba-L free par- ticles by dendritic cells to autologous T lymphocytes Figure 5
Ability of plant lectins to inhibit transfer of HIV-1Ba-L free par-
ticles by dendritic cells to autologous T lymphocytes. Den-
dritic cells (MDDC) were incubated with non-toxic 
concentrations of each plant lectin and 0.5 ng p24 antigen of 
virus were added for 3 h. The HIV-production by T cells was 
evaluated on the 6th day of co-culture by measurement of 
p24 antigen by ELISA. Means of three independent experi-
ments are presented; error bars represent standard devia-
tions. *< 0.05, **< 0.01.
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of effect of mannan, (iii) α(1–3) mannosylated close to
HIV-binding site, as indicated both by the lack of inhibi-
tory effect on HIV adsorption in the presence of HHA and
by the interaction of HHA with epithelial cells receptors.
The identification of this (or these) molecule(s) remains
to be performed.
We further assessed the role of both plant lectins on HIV
transcytosis. Hocini and al. have previously demonstrated
a partial inhibitory effect of mannan in transcytosis [8],
thus involving a C-type lectin, conversely to adsorption
phase. Only HHA, but not GNA, inhibited HIV-1JR-CSF
transcytosis in a dose-dependent manner. Whereas GNA
has a specificity for terminal α(1–3)-linked mannose res-
idues, HHA recognizes both terminal and internal α(1–3)
and α(1–6)-linked mannose residues [9]. Whether this
additional specificity of HHA is the reason for the effect of
this plant lectin on transcytosis remains to be demon-
strated. Since HHA inhibited specifically transcytosis and
faint to inhibit HIV-1 adsorption, we confirm herein that
adsorption and transcytosis of HIV are likely two distinct
phenomenons involving in the latter one (a) C-type lec-
tin(s) and HHA-interacting mannosylated molecule(s)
[12]. Involvement of a single HIV-interacting molecule
exhibiting mannosylation close to the C-type lectin region
(CLR domain) within the transcytosis phase is also possi-
ble. HEC-1 epithelial cells used in our model do not
express mannose receptor [19] nor DC-SIGN molecule
[15], which could be involved in cell-free HIV-1 particles
endocytosis (data not shown).
We evaluated the role of lectins on HIV adsorption on
MDDC, representing one of the primary HIV target cells in
the course of sexual transmission [13]. Similarly to MDM,
HIV is adsorbed on MDDC via C-type lectins [15], synde-
cans [20], and to some extent CD4 [21]. However, the
diversity of C-type lectins expressed on MDDC is broader
to that expressed on MDM, as illustrated by the restricted
expression of DC-SIGN or DEC-205 on MDDC [22,23].
Nevertheless, if some C-type lectins interact with HIV,
recent data suggest a specific role for each HIV-interacting
C-type lectins. Thus, the mannose receptor seems to be
more involved in HIV attachment and internalization
whereas DC-SIGN seems to be more involved in the trans-
fer of infectious viruses to susceptible CD4+ T cells [24]. In
that context, our results indicated that both plant lectins
partially inhibited HIV attachment on MDDC at the high-
est concentration tested (100 µg/ml), similarly to man-
nan. Therefore, these results strongly suggest that : (i) both
HHA and GNA interact with MDDC surface proteins
exhibiting terminal α(1–3)-mannosylation ; (ii) some of
these mannosylated proteins interact with HIV in a man-
ner which could be inhibited by plant lectin interaction,
and (iii) that some of these mannosylated proteins could
be C-type lectins, considering the blocking effect of man-
nan and the relative role of those lectins, syndecans and
CD4 in HIV adsorption on MDDC. Interestingly, a recent
report has described a selective tissus-specific mannosyla-
tion of the mannose receptor on macrophages which
could react in some cases with GNA [25]. Thus, it is also
tempting to suggest that the mannose receptor could be
mannosylated close to the HIV binding site when
expressed on MDDC, conversely to an unmannosylated
form of the mannose receptor expressed on MDM, there-
fore explaining the observed difference between the plant-
lectin effects on MDDC and on epithelial cells.
Finally, we assessed the role of HIV-lectins pre-treatment
on MDDC to T cells transfer of HIV. Our results showed a
modest decrease of HIV transfer between MDDC and PBL.
In addition, this down-modulation was inferior to that
observed for HIV adsorption on MDDC in the presence of
lectins. In the system we used, unbound plant lectins were
eliminated by washing treated-MDDC before the addition
of T cells, in order to focus exclusively on the effect of
adsorbed plant-lectin on MDDC. Our observations sug-
gest that plant lectins act on MDDC more specifically on
adsorption than on the transfer phase. This weak effi-
ciency of plant lectins to inhibit HIV-1 transfer was also
reported in a recent published study which was performed
using cell lines (Raji/DC-SIGN cell system and C8166 T
cell line [5]. Recently, it was reported that dendritic cells
expressed a large array of receptors implicated on the HIV-
1 attachment and/or transfer [2]. In particular, Turville
and colleagues reported that dendritic cells do not express
DC-SIGN but mannosylated receptors in tissues-where
HIV-1 is captured by dendritic cells-, whereas in lymph
nodes-where transfer to T cells occurs- dendritic cells
express largely DC-SIGN, suggesting that receptors
involved in attachment and transfer are different [2]. In
the present study, HHA inhibited as efficiently as GNA
HIV-1 adsorption on dendritic cells, but only HHA inhib-
ited HIV-1 transfer from MDDC to T cells, suggesting that
HIV-1 receptors invloved in HIV attachment and in HIV-1
transfer may be different, and that HHA and GNA may
interact with different(s) receptor(s).
Our observations demonstrate furthermore higher inhib-
itory activities of the lectin plant HHA by comparison to
GNA, on HIV adsorption to HEC-1A cell line, HIV transcy-
tosis through HEC-1A cell line monolayer, HIV adsorp-
tion to MDDC and HIV transfert from MDDC to T cells,
highlighting the potential interest of HHA as effective
microbicide against HIV. These findings may have high
relevance to be taken into account for the choice and
development of microbicide molecule candidates, and
likely suggest to retain for further investigations the
microbicide molecule candidate the most effective to
inhibit HIV in various in vitro systems mimicking the
attachment of the virus to mucosal target cells and theJournal of Translational Medicine 2007, 5:28 http://www.translational-medicine.com/content/5/1/28
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transport of HIV through the mucosa. Combination prod-
ucts could in principle provide a greater degree of protec-
tion than single agents, a broader spectrum of activity
against various pathogens and a lower risk of adverse reac-
tions. Since high concentration of HHA are necessary to
inhibit the adsorption on the HIV target cells, the combi-
nation of HHA derivates with one or two other compo-
nent(s) would allow a lower dose of this component.
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